Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 5Phase 1/2 5Phase 1 2Phase 2/3 1

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Tumor-Agnostic 1

Conditions

Small Cell Lung Carcinoma 1Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 133Carboplatin 132Cisplatin 119Paclitaxel 104Gemcitabine 89Specimen Handling 82Magnetic Resonance Spectroscopy 82Docetaxel 73Dexamethasone 60Cyclophosphamide 60Pemetrexed 57durvalumab 55Bevacizumab 55Capecitabine 54Radiotherapy 51Doxorubicin 51Oxaliplatin 50Fluorouracil 48Radiation 47Rituximab 43Leucovorin 43Vincristine 41Lenalidomide 40Etoposide 39atezolizumab 37Nivolumab 37Letrozole 36130-nm albumin-bound paclitaxel 32Bortezomib 31Prednisone 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Tiragolumab × 90 days × Clear all
NCT04513925 2026-06-03

SKYSCRAPER-03

Hoffmann-La Roche

Phase 3 Completed
829 enrolled 40 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05862285 2026-05-12

UmbrellaMAX

Hoffmann-La Roche

Phase 3 Recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

NCT04543617 2026-04-17

SKYSCRAPER-07

Hoffmann-La Roche

Phase 3 Active not recruiting
760 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04540211 2026-04-09

SKYSCRAPER-08

Hoffmann-La Roche

Phase 3 Completed
461 enrolled 24 charts
Gastrointestinal

Esophageal Neoplasms

NCT04256421 2026-04-03

SKYSCRAPER-02

Hoffmann-La Roche

Phase 3 Completed
490 enrolled 33 charts
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡